FDA Adverse Event Malfunction Summary report: N

STERLING?

MDR report key: 23003779 · Received September 9, 2025

Report

Report Number
2124215-2025-63217
Event Type
Malfunction
Date Received
September 9, 2025
Date of Event
August 13, 2025
Report Date
December 4, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
LIT
UDI-DI
08714729859611
PMA / PMN Number
K141150
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

G4 - PREMARKET / 510(K) #: K141150, K162350.

Additional Manufacturer Narrative · 0

UPDATED E1: INITIAL REPORTER FIRST NAME. UPDATED E1: INITIAL REPORTER EMAIL. G4 - PREMARKET / 510(K) #: K141150, K162350.

Description of Event or Problem · 0

IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. THE 100% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND SEVERELY CALCIFIED SUPERFICIAL FEMORAL ARTERY. A 6.0MMX150MMX150CM STERLING BALLOON CATHETER WAS ADVANCED FOR DILATATION. DURING THE PROCEDURE, THE BALLOON RUPTURED AFTER FIRST INFLATION AT 10 ATMOSPHERES. THE DEVICE WAS REMOVED USING NORMAL METHOD WITHOUT ISSUE AND THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. THERE WAS NO PATIENT INJURY AS A RESULT OF THIS EVENT.

Description of Event or Problem · 0

IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. THE 100% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND SEVERELY CALCIFIED SUPERFICIAL FEMORAL ARTERY. A 6.0MMX150MMX150CM STERLING BALLOON CATHETER WAS ADVANCED FOR DILATATION. DURING THE PROCEDURE, THE BALLOON RUPTURED AFTER FIRST INFLATION AT 10 ATMOSPHERES. THE DEVICE WAS REMOVED USING NORMAL METHOD WITHOUT ISSUE AND THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. THERE WAS NO PATIENT INJURY AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2406858 STERLING? CATHETER, PERCUTANEOUS LIT BOSTON SCIENTIFIC CORPORATION H74939031601610 0030024882 08714729859611

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown